Related Experiment Video
Updated: Aug 8, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Metabotropic glutamate receptors and epilepsy
Jorge Ure1, Michel Baudry, Mónica Perassolo
1Department of Neurology, Borda Hospital, Universidad de Buenos Aires, Ramón Carrillo 375, Buenos Aires, Argentina. jorgeure@hotmail.com
Metabotropic glutamate receptors (mGluRs) are crucial in epilepsy development and seizure spread. Modulating mGluR activity offers promising therapeutic strategies for epilepsy treatment.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Metabotropic glutamate receptors (mGluRs) are implicated in the transition from interictal to ictal states in epilepsy.
- mGluRs influence the recruitment of healthy brain tissue into seizure activity, facilitating seizure propagation.
Purpose of the Study:
- To review the role of mGluRs in epilepsy.
- To explore the therapeutic potential of modulating mGluR activity for epilepsy treatment.
Main Methods:
- Review of existing literature on mGluRs and epilepsy.
- Analysis of structural features of mGluRs for drug development.
- Consideration of mechanisms underlying epileptogenesis.
Main Results:
- mGluRs are key players in seizure initiation and propagation.
- Structural diversity of mGluRs allows for targeted modulation by synthetic compounds.
- Dysregulation of mGluR signaling (e.g., group I hyperactivation, group II/III deficits) is observed in some epilepsies.
Conclusions:
- Targeting mGluR signaling pathways presents novel therapeutic avenues for epilepsy.
- Pharmacological modulation of mGluRs holds promise for developing new anti-epileptic treatments.
More Related Videos
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Ligand-Gated Ion Channel Receptor: Gating Mechanism

